期刊文献+

Prediction of sites under adaptive evolution in flavin-containing monooxygenases: Selection pattern revisited 被引量:1

Prediction of sites under adaptive evolution in flavin-containing monooxygenases: Selection pattern revisited
原文传递
导出
摘要 Flavin-containing monooxygenase (FMO), like cytochrome P450 (CYP), is a monooxygenase that uses the reducing equivalents of NADPH to reduce one atom of molecular oxygen to water, while the other atom is used to oxidize the substrate. Recently, it was shown that some CYP isoforms have been subject to positive selection. However, it is unknown whether the highly conserved phase I detoxification enzyme, FMO, has undergone similar positive Darwinian selection. We used maximum-likelihood models of codon substitution, evolutionary fingerprinting, and cross species comparison to investigate the occurrence of adaptive evolution in FMO sequences. We used recent genomic data from a range of species, including vertebrates and invertebrates. We present the evidence for the occurrence of adaptive evolution in mammalian FMO 3, 4, 5, and fugu FMOs but not in mammalian FMO 1, FMO 2, frog FMOs, other fish FMOs and invertebrate FMOs. The sites under adaptive evolution were significantly associated with the insertion domain in mammalian FMO 5. We identified specific amino acid sites in FMOs 3–5 that are likely targets for selection based on the patterns of parallel amino acid change. The most likely role of adaptive evolution is the repair of mutations that permitted optimal NADP+ binding and improved catalytic efficiency. The occurrence of positive selection during the evolution of phase I detoxification enzymes such as FMOs 3–5 and fugu FMO suggests the occurrence of both high selection pressure acting on species within their unique habitats and significant changes in intensity and direction (forms of xenobiotics and drugs) resulting from changes in microhabitat and food. Flavin-containing monooxygenase (FMO), like cytochrome P450 (CYP), is a monooxygenase that uses the reducing equivalents of NADPH to reduce one atom of molecular oxygen to water, while the other atom is used to oxidize the substrate. Recently, it was shown that some CYP isoforms have been subject to positive selection. However, it is unknown whether the highly conserved phase I detoxification enzyme, FMO, has undergone similar positive Darwinian selection. We used maximum-likelihood models of codon substitution, evolutionary fingerprinting, and cross species comparison to investigate the occurrence of adaptive evolution in FMO sequences. We used recent genomic data from a range of species, including vertebrates and invertebrates. We present the evidence for the occurrence of adaptive evolution in mammalian FMO 3, 4, 5, and fugu FMOs but not in mammalian FMO 1, FMO 2, frog FMOs, other fish FMOs and invertebrate FMOs. The sites under adaptive evolution were significantly associated with the insertion domain in mammalian FMO 5. We identified specific amino acid sites in FMOs 3-5 that are likely targets for selection based on the patterns of parallel amino acid change. The most likely role of adaptive evolution is the repair of mutations that permitted optimal NADP+ binding and improved catalytic efficiency. The occurrence of positive selection during the evolu- tion of phase I detoxification enzymes such as FMOs 3-5 and fugu FMO suggests the occurrence of both high selection pressure acting on species within their unique habitats and significant changes in intensity and direction (forms of xenobiotics and drugs) resulting from changes in microhabitat and food.
出处 《Chinese Science Bulletin》 SCIE EI CAS 2011年第12期1246-1255,共10页
基金 supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2008ZX10005-004) Educational Commission of Liaoning Province of China (2009A120) China Postdoctoral Science Foundation (20080440019 and 200902069)
关键词 适应性进化 单加氧酶 选择模式 网站 细胞色素P450 无脊椎动物 FMOs 预测 flavin-containing monooxygenase, adaptive evolution, positive selection, insertion domain, evolutionary fingerprint,maximum likelihood
  • 相关文献

参考文献44

  • 1Krueger S K, Williams D E. Mammalian flavin-containing monooxygenases: Structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther, 2005, 106:357-387. 被引量:1
  • 2Phillips I R, Shephard E A. Flavin-containing monooxygenases: Mutations, disease and drug response. Trends Pharmacol Sci, 2008, 29: 294-301. 被引量:1
  • 3Qiu H, Taudien S, Herlyn H, et al. CYP3 phylogenomics: Evidence for positive selection of CYP3A4 and CYP3A7. Pharmacogenet Genomics, 2008, 18:53-66. 被引量:1
  • 4Zawaira A, Marimba A, Masimirembwa C. Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites. Pharmacogenet Genomics, 2008, 18:467-476. 被引量:1
  • 5Chen X, Wang H, Zhou G, et al. Molecular population genetics of human CYP3A locus: Signatures of positive selection and implications for evolutionary environmental medicine. Environ Health Perspect, 2009, 117:1541-1548. 被引量:1
  • 6Allerston C K, Shimizu M, Fujieda M, et al. Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO 3). Pharmacogenet Genomics, 2007, 17:827-839. 被引量:1
  • 7Hao D C, Chen S L, Xiao P G, et al. Molecular phylogeny, long-term evolution, and functional divergence of flavin-containing monooxy- genases. Genetica, 2009, 137:173-187. 被引量:1
  • 8Sea Urchin Genome Sequencing Consortium. The genome of the sea urchin Strongylocentrotus purpuratus. Science, 2006, 314:941-952. 被引量:1
  • 9Eddy S R. Profile hidden Markov models. Bioinformatics, 1998, 14: 755-763. 被引量:1
  • 10Larkin M A, Blackshields G, Brown N P, et al. ClustalW and ClustalX version 2. Bioinformatics, 2007, 23:2947-2948. 被引量:1

同被引文献11

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部